Marcus Evans has announced its 2nd Annual Product and Pipeline Enhancement for Generics conference on "Formulating a Concrete Plan for Sustainability in the Rapidly Changing Global Generic Pharmaceutical Market." The conference, to be held on June 29-30, 2009 in Washington, DC, will offer presentations on the following topics:
• Ensuring the sustainability of the generics industry;
• Devising a risk-balanced patent strategy to mitigate potential lawsuits;
• Recent developments in the law impacting Hatch-Waxman litigation;
• Integrating your patent and regulatory strategies;
• Comprehending the factors involved in a profitable IP strategy;
• Best practices for navigating the global biogenerics terrain;
• Important considerations when breaking into the biogenerics market;
• Encouraging a tighter focus on innovative projects through strong project execution;
• Focusing on core competencies to overcome shrinking innovator pipelines;
• The impact of the globalization of the pharmaceutical industry;
• Achieving global success in the generics industry through strategic partnering;
• Securing your supply chain through strong API relationships;
• Understanding the global healthcare climate to ensure an accurate pricing strategy;
• Insight on changing standards in generics regulation;
• Developing a specialty product strategy to ensure a prosperous portfolio; and
• Avoiding the commoditization of your generic products.
• Devising a risk-balanced patent strategy to mitigate potential lawsuits;
• Recent developments in the law impacting Hatch-Waxman litigation;
• Integrating your patent and regulatory strategies;
• Comprehending the factors involved in a profitable IP strategy;
• Best practices for navigating the global biogenerics terrain;
• Important considerations when breaking into the biogenerics market;
• Encouraging a tighter focus on innovative projects through strong project execution;
• Focusing on core competencies to overcome shrinking innovator pipelines;
• The impact of the globalization of the pharmaceutical industry;
• Achieving global success in the generics industry through strategic partnering;
• Securing your supply chain through strong API relationships;
• Understanding the global healthcare climate to ensure an accurate pricing strategy;
• Insight on changing standards in generics regulation;
• Developing a specialty product strategy to ensure a prosperous portfolio; and
• Avoiding the commoditization of your generic products.
A brochure for this conference can be requested here. The registration fee for the conference is $2,500. Those interested in registering for the conference can do so here.
Comments